Clinical Trial Update: Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of CS0159 in combination with semaglutide for patients with Metabolic Dysfunction-Associated Steat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• CS0159
• semaglutide (semaglutide)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Metabolic Dysfunction-Associated Steatohepatitis (MASH), Obesity | NA | Status: COMPLETED